| Date Filed | Type | Description |
| 05/26/2023 |
4
| MILLIGAN JOHN F (Director) has filed a Form 4 on PACIFIC BIOSCIENCES OF CALIFORNIA, INC.|
Txns:
| Granted 25,775 options to buy
@ $11.94, valued at
$307.8k
|
|
| 05/25/2023 |
4
| MILLIGAN JOHN F (Director) has filed a Form 4 on 4D Molecular Therapeutics, Inc.|
Txns:
| Granted 33,750 options to buy
@ $17.98, valued at
$606.8k
|
|
| 05/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/25/2022 |
4
| MILLIGAN JOHN F (Director) has filed a Form 4 on 4D Molecular Therapeutics, Inc.|
Txns:
| Granted 33,750 options to buy
@ $7.77, valued at
$262.2k
|
|
| 06/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/17/2020 |
4
| MILLIGAN JOHN F (Director) has filed a Form 4 on 4D Molecular Therapeutics Inc.|
Txns:
| Bought 100,000 shares
@ $23, valued at
$2.3M
|
|
| 12/10/2020 |
3
| MILLIGAN JOHN F (Director) has filed a Form 3 on 4D Molecular Therapeutics Inc. |
| 10/19/2020 |
4
| MILLIGAN JOHN F (Director) has filed a Form 4 on PACIFIC BIOSCIENCES OF CALIFORNIA, INC.|
Txns:
| Granted 35,000 options to buy
@ $14.34, valued at
$501.9k
|
|
| 08/26/2020 |
4
| MILLIGAN JOHN F (Director) has filed a Form 4 on PACIFIC BIOSCIENCES OF CALIFORNIA, INC.|
Txns:
| Exercised 35,000 options to buy
@ $2.67, valued at
$93.5k
Exercised 25,000 options to buy
@ $4.45, valued at
$111.3k
Exercised 25,000 options to buy
@ $3.81, valued at
$95.3k
Exercised 25,000 options to buy
@ $2.61, valued at
$65.3k
|
|
| 08/06/2020 |
4
| MILLIGAN JOHN F (Director) has filed a Form 4 on PACIFIC BIOSCIENCES OF CALIFORNIA, INC.|
Txns:
| Granted 97,785 options to buy
@ $3.89, valued at
$380.4k
|
|
| 11/29/2018 |
4
| MILLIGAN JOHN F (President and CEO) has filed a Form 4 on GILEAD SCIENCES INC|
Txns:
| Exercised 280,000 options to buy
@ $23.6, valued at
$6.6M
|
|
| 05/23/2018 |
4
| MILLIGAN JOHN F (Director) has filed a Form 4 on PACIFIC BIOSCIENCES OF CALIFORNIA, INC.|
Txns:
| Granted 25,000 options to buy
@ $2.61, valued at
$65.3k
|
|
| 05/08/2018 |
4
| MILLIGAN JOHN F (President and CEO) has filed a Form 4 on GILEAD SCIENCES INC|
Txns:
| Exercised 80,000 options to buy
@ $27.07, valued at
$2.2M
|
|
| 02/23/2018 |
4
| MILLIGAN JOHN F (President and CEO) has filed a Form 4 on GILEAD SCIENCES INC|
Txns:
| Granted 340 shares
@ $62.3475, valued at
$21.2k
Granted 48,342 shares
@ $0
Granted 7,709 shares
@ $0
Paid exercise price by delivering 8,009 shares
@ $80.69, valued at
$646.2k
|
|
| 02/05/2018 |
4
| MILLIGAN JOHN F (President and CEO) has filed a Form 4 on GILEAD SCIENCES INC|
Txns:
| Granted 295,660 options to buy
@ $83.49, valued at
$24.7M
|
|
| 11/15/2017 |
4
| MILLIGAN JOHN F (President and CEO) has filed a Form 4 on GILEAD SCIENCES INC|
Txns:
| Sold 220,000 shares
@ $72.8849, valued at
$16M
Exercised 220,000 options to buy
@ $21.575, valued at
$4.7M
|
|
| 05/25/2017 |
4
| MILLIGAN JOHN F (Director) has filed a Form 4 on PACIFIC BIOSCIENCES OF CALIFORNIA, INC.|
Txns:
| Granted 25,000 options to buy
@ $3.81, valued at
$95.3k
|
|
| 02/27/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/21/2017 |
4
| MILLIGAN JOHN F (President and CEO) has filed a Form 4 on GILEAD SCIENCES INC|
Txns:
| Granted 315 shares
@ $59.33, valued at
$18.7k
Granted 11,606 shares
@ $0
Granted 3,429 shares
@ $0
Paid exercise price by delivering 8,389 shares
@ $70.31, valued at
$589.8k
|
|
| 02/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/08/2016 |
4
| MILLIGAN JOHN F (President and CEO) has filed a Form 4 on GILEAD SCIENCES INC|
Txns:
| Sold 70,000 shares
@ $77.744, valued at
$5.4M
Exercised 70,000 options to buy
@ $20.74, valued at
$1.5M
|
|
| 08/03/2016 |
4
| MILLIGAN JOHN F (President and CEO) has filed a Form 4 on GILEAD SCIENCES INC|
Txns:
| Sold 70,000 shares
@ $70.937, valued at
$5M
Exercised 70,000 options to buy
@ $20.74, valued at
$1.5M
|
|
| 07/07/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/08/2016 |
4
| MILLIGAN JOHN F (President and CEO) has filed a Form 4 on GILEAD SCIENCES INC|
Txns:
| Sold 52,819 shares
@ $86.5732, valued at
$4.6M
Sold 59,181 shares
@ $87.2589, valued at
$5.2M
Exercised 112,000 options to buy
@ $16.395, valued at
$1.8M
|
|
| 05/19/2016 |
4
| MILLIGAN JOHN F (Director) has filed a Form 4 on PACIFIC BIOSCIENCES OF CALIFORNIA, INC.|
Txns:
| Granted 25,000 options to buy
@ $8.98, valued at
$224.5k
|
|
| 05/04/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/05/2016 |
4
| MILLIGAN JOHN F (President and CEO) has filed a Form 4 on GILEAD SCIENCES INC|
Txns:
| Sold 96,164 shares
@ $94.5412, valued at
$9.1M
Sold 15,836 shares
@ $94.8752, valued at
$1.5M
Exercised 112,000 options to buy
@ $16.395, valued at
$1.8M
|
|
| 03/03/2016 |
4
| MILLIGAN JOHN F (President, COO and Director) has filed a Form 4 on GILEAD SCIENCES INC|
Txns:
| Sold 112,000 shares
@ $87.7946, valued at
$9.8M
Exercised 112,000 options to buy
@ $16.395, valued at
$1.8M
|
|
| 02/18/2016 |
4
| MILLIGAN JOHN F (President, COO and Director) has filed a Form 4 on GILEAD SCIENCES INC|
Txns:
| Granted 248 shares
@ $76.024, valued at
$18.9k
Granted 16,246 shares
@ $0
Granted 58,794 shares
@ $0
Paid exercise price by delivering 45,433 shares
@ $91.15, valued at
$4.1M
|
|
| 11/12/2013 |
4
| MILLIGAN JOHN F (President and COO) has filed a Form 4 on GILEAD SCIENCES INC|
Txns:
| Sold 217,793 shares
@ $66.9667, valued at
$14.6M
Sold 177,842 shares
@ $68.1841, valued at
$12.1M
Exercised 395,635 options to buy
@ $7.6325, valued at
$3M
|
|
| 07/18/2013 |
4
| MILLIGAN JOHN F (Director) has filed a Form 4 on PACIFIC BIOSCIENCES OF CALIFORNIA, INC. |
| 07/18/2013 |
3
| MILLIGAN JOHN F (Director) has filed a Form 3 on PACIFIC BIOSCIENCES OF CALIFORNIA, INC. |
| 03/08/2013 |
4
| MILLIGAN JOHN F (President and COO) has filed a Form 4 on GILEAD SCIENCES INC|
Txns:
| Granted 49,000 shares
@ $0
Paid exercise price by delivering 25,568 shares
@ $45.4, valued at
$1.2M
|
|
|